PLU Ophthalmic
Share
Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from PLU Ophthalmic, Medical and health, Miami, FL.
Filtration surgery works. It just doesn't all work the same way. Filtration can involve a permanent implant or a more invasive surgical approach.
AquaLumen® was designed with a clear objective: to achieve subconjunctival filtration while rethinking what it requires to get there. That objective led to three deliberate design decisions that we are covering in the next posts. Stay tuned!
Specs at AquaLumen.net
09/16/2026
No two glaucoma patients follow the same journey. Treatment decisions depend on disease progression, medication burden, target IOP, tissue health, and surgical history.
That's why successful glaucoma surgery begins with understanding the patient, not simply choosing the procedure. Swipe through to explore how different clinical journeys shape different treatment decisions.
Explore more educational resources and discover how AquaLumen® supports individualized treatment planning at AquaLumen.net.
09/10/2026
Treatment decisions aren't only about where a patient is today.They're about where the disease is heading.
For patients requiring a lower target IOP, earlier filtration becomes an important part of the conversation. Every treatment decision should balance efficacy, tissue preservation, and future surgical flexibility.
Explore the clinical evidence supporting earlier filtration and discover where AquaLumen® fits within today's treatment strategy.
Learn more at AquaLumen.net.
09/08/2026
The glaucoma treatment continuum is evolving. Between angle-based procedures and traditional filtration surgery, a new conversation is emerging around earlier filtration.
AquaLumen™ helps expand that conversation by introducing an implant-free, conjunctiva-sparing approach designed for patients requiring more than MIGS.
Because every stage of treatment should preserve future possibilities.
Interested in learning more about AquaLumen™ and its role in the glaucoma treatment continuum?
Visit AquaLumen.net.
The next treatment decision isn't based on one factor alone.
5 factors that shape the next treatment decision: Disease progression, target IOP, medication burden, conjunctival health, and previous procedures.
Each plays an important role in determining the most appropriate treatment pathway for every glaucoma patient. Successful glaucoma care starts with understanding the complete clinical picture and making thoughtful decisions every step of the way.
Clinical decisions begin with understanding the whole patient.
Visit AquaLumen.net to explore the clinical data and educational resources behind AquaLumen®.
Successful glaucoma management isn't measured only in millimeters of mercury.
For many patients, reducing medication burden is just as meaningful as lowering IOP. Earlier filtration may help achieve both by reaching lower target pressures while reducing dependence on daily medications.
That's why glaucoma care should be measured not only by pressure, but by the patient's long-term treatment experience.
Explore the clinical data behind AquaLumen™ and learn how reducing medication burden may contribute to a more comprehensive approach to glaucoma management.
Visit AquaLumen.net.
The best surgical outcomes don't begin in the operating room. They begin with thoughtful patient evaluation.
As glaucoma treatment continues to evolve, surgeons are placing greater emphasis on timing, tissue preservation, and selecting the right intervention for the right patient. Because better decisions today can create more possibilities tomorrow.
Explore how AquaLumen™ fits within today's evolving glaucoma treatment continuum.
Visit AquaLumen.net for additional clinical resources.
08/20/2026
Every glaucoma patient presents a unique clinical picture. Patient selection remains one of the most important factors in determining long-term surgical success.
Understanding disease progression, medication burden, target IOP, and tissue health helps guide treatment decisions that support better outcomes.
Learn more about patient selection, earlier filtration, and the clinical evidence supporting AquaLumen™ at AquaLumen.net
For appropriately selected patients, reaching a lower target IOP earlier in the disease can shape long-term management.
What has traditionally made surgeons wait is the trade-off: Conventional filtration requires opening the conjunctiva and committing tissue that may be needed later.
An implant-free, conjunctiva-sparing approach changes that benefit- risk equation. Earlier filtration becomes a realistic option without giving up what comes after.
As the treatment continuum evolves, so does the conversation around when filtration should begin.
Learn more about AquaLumen™ and the future of glaucoma surgery. Discover how AquaLumen™ is helping redefine the conversation around earlier filtration in glaucoma care.
Visit AquaLumen.net to learn more.
08/11/2026
Outcomes don't just depend on the procedure. They depend on who receives it.
From post MIGS patients requiring lower target IOP to surgery-naïve candidates and patients seeking alternatives to traditional filtration, patient selection remains one of the most important determinants of long-term success.
Swipe through five patient profiles where AquaLumen™ may provide meaningful value and why timing, tissue health, and treatment goals matter.
Click here to claim your Sponsored Listing.
Category
Website
Address
Alerts
Be the first to know and let us send you an email when PLU Ophthalmic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.